Our research projects

Bodyweight is one of many factors that influences risk of type 2 diabetes. But people with similar bodyweights can have different risks, so alone it doesn’t give us the full picture. Dr Hanieh Yaghootkar is looking at how genes influence where the body stores fat, and how different fat patterns may increase or decrease the risk of type 2 diabetes and its complications. Understanding this could help us to better predict who’s most at risk and lead to more effective, personalised care for people with or at risk of type 2 diabetes. 

Diabetes stigma is a serious problem and can have serious effects on people with diabetes’ physical and mental health. Professor Nick Oliver will look at the causes of type 1 diabetes stigma, explore how many people in the UK experience it and the impact it can have. Understanding the roots of type 1 diabetes stigma and how it evolves over time, could help to develop novel ways to manage or tackle it.

Type 2 diabetes can come with an increased risk of cardiovascular problems affecting the heart and blood vessels. Professor Stephen Wheatcroft wants to test ‘recipes’ for new molecules that can protect against these issues, and also treat type 2 diabetes. This could help researchers to develop new treatments for type 2 diabetes that also lower the risk of cardiovascular disease.

Established in 2011, ADDRESS-2 is a database of information from of people newly diagnosed with type 1 diabetes who have agreed to be involved in research. This new funding will continue to support the program and allow the team recruit more people. The team will work with the type 1 diabetes Immunotherapy Consortium to increase the number of people recruited into immunotherapy trials. These trials aim to find new ways to prevent, or cure, type 1 diabetes.

Diabetic foot ulcers can have a huge impact on people’s lives, and, in the most serious cases, infections can put people at risk of life-altering amputations. Dr Wilkinson wants to understand how bacteria cause infections and slow healing in foot ulcers in people with type 2 diabetes. This will help to develop new treatments that could protect people with diabetes against amputations.

Living with diabetes can increase the risk of kidney disease, which in turn increases the risk of heart disease. Professor Luigi Gnudi has found a new protein that can tune signalling molecules to protect kidney cells and blood vessels. Understanding how the protein does this could help researchers to develop new treatments that can heal damaged kidney cells and also lower the risk of heart and blood vessel problems for people living with diabetes. 

Not everyone with diabetes is diagnosed with the right type straight away. Professor Angus Jones wants to shed more light on how common misdiagnosis is and who could benefit from extra checks by analysing data from a large health study, called the UK Biobank. His insights could help more people with diabetes to get the right diagnosis, and the right care and advice. 

Cilia are tiny, hair-like structures that help cells communicate. Dr Nalia Haq is studying whether cilia problems in insulin-making beta cells contribute to the development of type 1 diabetes,  or result from it. Her findings could help us better understand the root causes of type 1 diabetes, and point to targets for new treatments to slow or prevent it.

Many people with type 2 diabetes also experience depression. But we don’t know which existing diabetes treatments could also treat depression in people living with both conditions. Dr Gao is providing much-needed evidence to fill this knowledge gap. Her work could help to shape more personalised care so people get treatments that help them manage both conditions, without needing extra medications.  

Some people with diabetes go on to develop problems with the nerves in their feet. This is known as peripheral neuropathy and can affect safe driving. Professor Marple-Horvat is investigating if a driving stimulator and feedback system can help people with peripheral neuropathy get back to driving safely again, and keep their independence.